Major beta blocker mortality trials in chronic heart failure: a critical review.
McMurray
J J
JJ
CRI in Heart Failure, Wolfson Building, University of Glasgow, Glasgow G12 8QQ. j.mcmurray@bio.gla.ac.uk
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D017298:Bisoprolol / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality*; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use; D009017:Morbidity; D015337:Multicenter Studies as Topic; D011412:Propanolamines / Q000627:therapeutic use; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000188:drug therapy / Q000401:mortality
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D008790:Metoprolol; D017298:Bisoprolol